Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and...